T. Nagai

发表

Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit.

S. Ichiyama, I. Sakurabayashi, Kazuo Kobayashi, 2008, American journal of respiratory and critical care medicine.

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy

I. Kawase, Y. Fujio, J. Azuma, 2012, European Journal of Clinical Pharmacology.

Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional study

T. Tabuchi, H. Iso, T. Takatorige, 2011, BMC infectious diseases.

IS6110 DNA fingerprinting analysis of individually separated colonies of Mycobacterium tuberculosis.

H. Ano, T. Takashima, Tomoshige Matsumoto, 2005, Tuberculosis.

Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents.

Satomu Morita, Hidekazu Suzuki, T. Hirashima, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[Clinical study on nosocomial infection of Pseudomonas aeruginosa. II. Pseudomonas aeruginosa in the feces and urinary Pseudomonas aeruginosa infection].

T. Hirose, Y. Kumamoto, T. Nagai, 1982, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Serological diagnosis of pulmonary tuberculosis and nontuberculous pulmonary mycobacteriosis].

Yasushi Watanabe, T. Nagai, N. Oketani, 2001, Kekkaku : [Tuberculosis].

Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)

Toshio Tanaka, T. Hirashima, H. Matsuoka, 2021, Journal of Clinical Virology.

Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study

Toshio Tanaka, Hidekazu Suzuki, T. Hirashima, 2020, Journal of Infection and Chemotherapy.

[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy].

K. Kawahara, H. Ano, T. Takashima, 2006, Kekkaku : [Tuberculosis].

Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan.

Y. Kusunoki, I. Takamatsu, T. Suetake, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19

Toshio Tanaka, T. Shioda, K. Yoshizaki, 2021, Frontiers in Medicine.

Simultaneous and Longitudinal Comparison of Interferon Gamma Release Assay Data from Health Care Workers in Japan

Koichi Suzuki, Y. Hoshino, Tomoshige Matsumoto, 2013 .

Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

Hidekazu Suzuki, A. Nishitani, M. Fujishima, 2018, BMC Cancer.

I. Kawase, Y. Fujio, J. Azuma, 2012, European Journal of Clinical Pharmacology.

Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study

I. Kawase, Hidekazu Suzuki, M. Fujishima, 2014, BMC Cancer.

Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

Hidekazu Suzuki, A. Nishitani, M. Fujishima, 2018, BMC Cancer.

Transbronchial Cryobiopsy for Miliary Tuberculosis Mimicking Hypersensitivity Pneumonitis

Hidekazu Suzuki, K. Kawahara, T. Hirashima, 2020, Internal medicine.